Co-Authors
This is a "connection" page, showing publications co-authored by CLAUDIO ESTEVES TATSUI and ANDREW J BISHOP.
Connection Strength
1.893
-
Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother Oncol. 2024 Apr; 193:110119.
Score: 0.246
-
Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. J Neurosurg Spine. 2020 Dec 11; 34(3):354-363.
Score: 0.198
-
A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine. 2020 Jan 03; 1-9.
Score: 0.186
-
A Novel Use of the Intraoperative MRI for Metastatic Spine Tumors: Laser Interstitial Thermal Therapy for Percutaneous Treatment of Epidural Metastatic Spine Disease. Neurosurg Clin N Am. 2017 Oct; 28(4):513-524.
Score: 0.157
-
Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017 Sep; 27(3):303-311.
Score: 0.156
-
Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1016-1026.
Score: 0.134
-
Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma. J Neurosurg Spine. 2015 Jan; 22(1):52-9.
Score: 0.131
-
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol. 2023 Sep; 164(2):377-386.
Score: 0.060
-
Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J. 2023 Mar; 41(1):12-22.
Score: 0.058
-
Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):e7-e13.
Score: 0.056
-
Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2023 Jan 01; 96(1141):20220267.
Score: 0.056
-
Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol. 2020 11; 152:49-55.
Score: 0.048
-
Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol. 2020 Jun; 148(2):327-334.
Score: 0.047
-
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine. 2020 Feb 14; 1-9.
Score: 0.047
-
Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. Radiother Oncol. 2019 09; 138:80-85.
Score: 0.045
-
National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg. 2019 Apr; 124:e580-e594.
Score: 0.043
-
Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery. Pract Radiat Oncol. 2019 Mar; 9(2):e142-e148.
Score: 0.043
-
Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1207-1215.
Score: 0.039
-
Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. J Radiosurg SBRT. 2017; 5(1):25-34.
Score: 0.038
-
Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1405-1413.
Score: 0.036
-
Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine. 2016 May; 24(5):829-36.
Score: 0.035
-
Creation of a Prognostic Index for Spine Metastasis to Stratify Survival in Patients Treated With Spinal Stereotactic Radiosurgery: Secondary Analysis of Mature Prospective Trials. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):118-25.
Score: 0.034